Postpartum Depression

Oral Allopregnanolone Analogue for Postpartum Depression Treatment

In 2015, we first reported on SAGE-547 (SAGE Therapeutics), a new medication for the treatment of postpartum depression (PPD).  SAGE-547, now called brexanolone, is a neurosteroid, an analogue of allopregnanolone and an allosteric modulator of [...]

By |2019-01-13T15:57:09-04:00January 14th, 2019|Medication, Postpartum Depression, Postpartum Psychiatric Disorders, Treatment|Comments Off on Oral Allopregnanolone Analogue for Postpartum Depression Treatment

In Brief: Mothers with Affective Illness (Even In Remission) Have Deficits in Emotional Processing

We have long known that postpartum depression may have negative effects on the child and may contribute to deficits in social development and emotional regulation.  Exactly what mediates these effects is not so clear; however, [...]

By |2018-11-20T14:20:42-04:00November 20th, 2018|Child Outcomes, Postpartum Depression, Postpartum Psychiatric Disorders|Comments Off on In Brief: Mothers with Affective Illness (Even In Remission) Have Deficits in Emotional Processing

FDA Supports Intravenous Brexanolone for Postpartum Depression

In 2015, we first reported on SAGE-547 (SAGE Therapeutics), a new medication for the treatment of postpartum depression (PPD).  SAGE-547, now called brexanolone, is an allosteric modulator of GABAA receptors.  Since that time, Sage Therapeutics [...]

By |2018-11-10T10:02:56-04:00November 10th, 2018|Medication, Postpartum Depression, Postpartum Psychiatric Disorders, Treatment|Comments Off on FDA Supports Intravenous Brexanolone for Postpartum Depression

In Brief: Asthma Doubles Risk of Postpartum Depression

In a recent study from Quebec, researchers compared the risk of postpartum depression in more than 35,000 pregnant women with asthma and almost 200,000 women without asthma.  They found that rates of postpartum depressive symptoms [...]

By |2018-11-08T10:58:08-04:00October 26th, 2018|Postpartum Depression, Postpartum Psychiatric Disorders, Prevalence & Risk Factors|Comments Off on In Brief: Asthma Doubles Risk of Postpartum Depression

Is Acupuncture Effective for Postpartum Depression?

In a recent meta-analysis, researchers screened electronic databases and analyzed data from randomized controlled trials (RCTs) of acupuncture for the treatment of postpartum depression (PPD). Primary outcomes included improvement in depressive symptoms, as by scores [...]

By |2018-11-08T11:00:14-04:00October 22nd, 2018|Alternative & Complementary, Postpartum Depression, Postpartum Psychiatric Disorders, Treatment|Comments Off on Is Acupuncture Effective for Postpartum Depression?

Brexanolone for Postpartum Depression: More Data, But Still Some Questions

In 2015, we first reported on SAGE-547 (SAGE Therapeutics), a new medication for the treatment of severe postpartum depression (PPD).  SAGE-547, now called brexanolone, is an allosteric modulator of GABA-A receptors.  We saw the preliminary [...]

By |2018-11-08T11:05:46-04:00September 26th, 2018|Medication, Postpartum Depression, Postpartum Psychiatric Disorders, Treatment|Comments Off on Brexanolone for Postpartum Depression: More Data, But Still Some Questions

Brexanolone: A New Drug for Postpartum Depression

In 2015, we first reported on SAGE-547 (SAGE Therapeutics), a new medication for the treatment of severe postpartum depression (PPD).  SAGE-547, now called brexanolone, is an allosteric modulator of GABAA receptors.  This drug was initially [...]

By |2018-06-15T11:29:21-04:00June 11th, 2018|Medication, Postpartum Depression, Postpartum Psychiatric Disorders, Treatment|Comments Off on Brexanolone: A New Drug for Postpartum Depression

Sacramento: What Can We Learn from a New Mother’s Experience of Postpartum Care?

Over the last few weeks, there has been a lot of coverage of a story involving a new mother from Sacramento.  You can read the details of the story here and here.  Basically, a new [...]

By |2018-03-08T02:33:27-04:00February 9th, 2018|Postpartum Depression, Postpartum Psychiatric Disorders, Treatment|Comments Off on Sacramento: What Can We Learn from a New Mother’s Experience of Postpartum Care?

How Are We Doing: What Happens to Women Who Screen Positive for Postpartum Depression?

  Postpartum depression (PPD) screening has been increasingly implemented not only in obstetric, but also in primary care and pediatric settings, over the past decade.  While there is a growing appreciation for the prevalence of [...]

By |2018-01-22T11:11:14-04:00January 22nd, 2018|Postpartum Depression, Postpartum Psychiatric Disorders|Comments Off on How Are We Doing: What Happens to Women Who Screen Positive for Postpartum Depression?

Postpartum depression: Moving toward improved screening with a new app

The following post was first published in OB/GYN News. Please see our OB/GYN News archives here. Publish date: November 22, 2017 Over the last several years, there’s been increasing interest and ultimately a growing number of mandates across [...]

By |2018-01-19T11:27:15-04:00January 19th, 2018|Postpartum Depression, Postpartum Psychiatric Disorders|Comments Off on Postpartum depression: Moving toward improved screening with a new app
Go to Top